Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Cardiology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Cardiology Other
    Distinguishing Mutations From Rare Variants Key to Interpreting Genetic Testing in LQTS - (DGNews)
    Small Increases In Phosphorus May Mean Higher Risk of Heart Disease - (DGNews)
    A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease - (N Engl J Med)
    ACC Revises Guidelines for Perioperative Use of Beta Blockers - (DGNews)
    Effect of tailored practice and patient care plans on secondary prevention of heart disease in general practice: cluster randomised controlled trial - (BMJ)

    News archive

     Recent webcasts/CME - Cardiology Other
      Comorbidity in Patients with Rheumatoid Arthritis: What are the Real Concerns?
      Sleep Apnea and the Importance of Patient Screening
      Patient-Centered Approaches to the Evaluation and Management of Atrial Fibrillation
      Current Concepts and Management Strategies in Atrial Flutter
      Cancer, Liver, Infections, Cardiovascular Disease, and other Biologic Agents

      Webcasts/CME archive

       Recent cases - Cardiology Other
        Multiorgan Paradoxical Embolism Consequent to Acute Pulmonary Thromboembolism with Patent Foramen Ovale: A Case Report
        A Long-Term Follow-Up of a Girl With Dilated Cardiomyopathy After Mitral Valve Replacement and Septal Anterior Ventricular Exclusion
        Cardiac Injuries in Blunt Chest Trauma
        Nonsurgical Management of a Tricuspid Valvular Pedunculated Papillary Fibroelastoma
        Atypical Atrial Myxomas in Two Asymptomatic Patients: A Case Report

        Cases archive
          




        my personal edition > cardiology other > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Managing Risk of Bleeding in Patients Prior to Antithrombotic Treatment Improves Outcomes

          SOPHIA ANTIPOLIS, France -- September 4, 2008 -- The appropriate management of acute coronary syndrome (ACS) has been shown over the last few decades to result in a significant improvement in outcome. However, the combined use of anticoagulants, antiplatelet agents, beta-blockers, and particularly antithrombotics may result in an excess of bleeding.

          Jean-Pierre Bassand, Department of Cardiology, Pôle Coeur Poumons, University Hospital Jean-Minjoz, Besançon Cedex, France, presented a study at the European Society of Cardiology 2008 Congress (ESC) on managing ACS and minimising the risk of bleeding.

          Until the recent past, bleeding was not considered to be a serious complication, but over the last 5 years, bleeding complications have in fact emerged as a major contributor to overall risk, with a significant increase in the rate of death, myocardial infarction (MI), and stroke in patients who suffer bleeding complications during the initial phase of ACS compared with those who do not.

          In addition, blood transfusions have been shown to result in a higher risk of death and are suspected to have deleterious effects in selected groups of patients.

          The risk factors for bleeding have been well identified. Older age, female sex, and low body weight have been identified as markers of the risk of bleeding. A past history of bleeding, the presence of renal failure, the use of an early invasive approach, excess doses of antithrombotic agents, and the use of glycoprotein IIb/IIIa inhibitors have also been identified as strong predictors of the risk of bleeding.

          Conversely, careful selection of drugs, giving precedence to drugs with less potential for bleeding, the use of a radial versus femoral approach for invasive strategy, and systematic use of proton pump inhibitors to avoid gastrointestinal bleeding during the initial phase are all measures that have the potential to reduce bleeding risk.

          In this context, some anticoagulants such as fondaparinux and bivalirudin have been shown to carry a lower risk of bleeding compared with low molecular weight heparins or unfractionated heparin. It would also appear that more consistent inhibition of platelet aggregation leads to better clinical outcomes, although with an increased risk of bleeding.

          Overall, bleeding and possible blood transfusions have emerged as major contributors to worse outcomes in patients with ACS. Proper management of patients, with appropriate selection of doses, drugs, and arterial approach, combined with systematic evaluation of the bleeding risk prior to starting therapy may help prevent bleeding and improve patient outcomes.

          SOURCE: European Society of Cardiology




        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send